Alcohol Addiction Therapeutics Market by Product Type and Application - Global Industry Analysis & Forecast to 2027

Published On : June 2022 Pages : 160 Category: Medical Devices Report Code : HC064067

Alcohol Addiction Therapeutics Market by Product Type (ADX-71441, ABT-436, A-705253, CTDP-002, CM-1212) Application (Clinic, Hospital, Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

Alcohol addiction therapeutics are utilized to treat the subjective and mental parts of liquor dependence. Alcohol addiction therapeutics offers different medicines, for example, homoeopathic, contemplation, restorative, and recovery focus. Liquor enslavement treatments rely upon the present wellbeing state of the patient and their issues.

Drivers and Restraints

Developing mindfulness about disadvantages of dependence on drinking liquor, for example, hypertension may harm heart muscle, stroke, cerebrum harm, liquor withdrawal disorder, and liver sickness is a central point expected to drive the development of the worldwide Alcohol addiction therapeutics market over the gauge time frame. Likewise, severe government guideline with respect to utilization of liquor is another key factor expected to fuel the development of the worldwide Alcohol addiction therapeutics market.

Regional Insights

The market in North America is relied upon to represent the most elevated income share in the worldwide market pursued by the market in Europe, attributable to expanding worry towards a sound way of life in nations in the district.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • AstraZeneca Plc
  • Allergan plc
  • Purdue Pharma L.P
  • GlaxoSmithKiline plc
  • Cipla Ltd.
  • Bionex Pharmaceuticals LLC
  • Pfizer Inc.
  • Kinnov Therapeutics SAS
  • Chronos Therapeutics Ltd.
  • Curemark LLC

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Alcohol Addiction Therapeutics Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)

o    ADX-71441

o    ABT-436

o    A-705253

o    CTDP-002

o    CM-1212

·         Alcohol Addiction Therapeutics Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o    Clinic

o    Hospital

o    Others

·         Alcohol Addiction Therapeutics Market, By Key Players

o    AstraZeneca Plc

o    Allergan plc

o    Purdue Pharma L.P

o    GlaxoSmithKiline plc

o    Cipla Ltd.

o    Bionex Pharmaceuticals LLC

o    Pfizer Inc.

o    Kinnov Therapeutics SAS

o    Chronos Therapeutics Ltd.

o    Curemark LLC

·         Alcohol Addiction Therapeutics Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Alcohol Addiction Therapeutics Market, By Country

o    U.S. Alcohol Addiction Therapeutics Market

o    Canada Alcohol Addiction Therapeutics Market

o    Mexico Alcohol Addiction Therapeutics Market

o    Europe

§  Europe Alcohol Addiction Therapeutics Market, By Country

o    Germany Alcohol Addiction Therapeutics Market

o    UK Alcohol Addiction Therapeutics Market

o    France Alcohol Addiction Therapeutics Market

o    Russia Alcohol Addiction Therapeutics Market

o    Italy Alcohol Addiction Therapeutics Market

o    Rest of Europe Alcohol Addiction Therapeutics Market

o    Asia-Pacific

§  Asia-Pacific Alcohol Addiction Therapeutics Market, By Country

o    China Alcohol Addiction Therapeutics Market

o    Japan Alcohol Addiction Therapeutics Market

o    South Korea Alcohol Addiction Therapeutics Market

o    India Alcohol Addiction Therapeutics Market

o    Southeast Asia Alcohol Addiction Therapeutics Market

o    Rest of Asia-Pacific Alcohol Addiction Therapeutics Market

o    South America

§  South America Alcohol Addiction Therapeutics Market

o    Brazil Alcohol Addiction Therapeutics Market

o    Argentina Alcohol Addiction Therapeutics Market

o    Columbia Alcohol Addiction Therapeutics Market

o    Rest of South America Alcohol Addiction Therapeutics Market

o    Middle East and Africa

§  Middle East and Africa Alcohol Addiction Therapeutics Market

o    Saudi Arabia Alcohol Addiction Therapeutics Market

o    UAE Alcohol Addiction Therapeutics Market

o    Egypt Alcohol Addiction Therapeutics Market

o    Nigeria Alcohol Addiction Therapeutics Market

o    South Africa Alcohol Addiction Therapeutics Market

o    Rest of MEA Alcohol Addiction Therapeutics Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Alcohol Addiction Therapeutics Market, By Product Type

5.1.     Introduction

5.2.     Global Alcohol Addiction Therapeutics Revenue and Market Share by Product Type (2017-2027)

5.2.1.  Global Alcohol Addiction Therapeutics Revenue and Revenue Share by Product Type (2017-2027)

5.3.     ADX-71441

5.3.1.  Global ADX-71441 Revenue and Growth Rate (2017-2027)

5.4.     ABT-436

5.4.1.  Global ABT-436 Revenue and Growth Rate (2017-2027)

5.5.     A-705253

5.5.1.  Global A-705253 Revenue and Growth Rate (2017-2027)

5.6.     CTDP-002

5.6.1.  Global CTDP-002 Revenue and Growth Rate (2017-2027)

5.7.     CM-1212

5.7.1.  Global CM-1212 Revenue and Growth Rate (2017-2027)

6.       Alcohol Addiction Therapeutics Market, By Application

6.1.     Introduction

6.2.     Global Alcohol Addiction Therapeutics Revenue and Market Share by Application (2017-2027)

6.2.1.  Global Alcohol Addiction Therapeutics Revenue and Revenue Share by Application (2017-2027)

6.3.     Clinic

6.3.1.  Global Clinic Revenue and Growth Rate (2017-2027)

6.4.     Hospital

6.4.1.  Global Hospital Revenue and Growth Rate (2017-2027)

6.5.     Others

6.5.1.  Global Others Revenue and Growth Rate (2017-2027)

7.       Alcohol Addiction Therapeutics Market, By Region

7.1.     Introduction

7.2.     Global Alcohol Addiction Therapeutics Revenue and Market Share by Regions

7.2.1.  Global Alcohol Addiction Therapeutics Revenue by Regions (2017-2027)

7.3.     North America Alcohol Addiction Therapeutics by Countries

7.3.1.  North America Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2027)

7.3.2.  North America Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Alcohol Addiction Therapeutics by Countries

7.4.1.  Europe Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Alcohol Addiction Therapeutics by Countries

7.5.1.  Asia-Pacific Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Alcohol Addiction Therapeutics by Countries

7.6.1.  South America Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2027)

7.6.2.  South America Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Alcohol Addiction Therapeutics by Countries

7.7.1.  Middle East and Africa Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     AstraZeneca Plc

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Allergan plc

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Purdue Pharma L.P

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     GlaxoSmithKiline plc

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Cipla Ltd.

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Bionex Pharmaceuticals LLC

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Pfizer Inc.

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Kinnov Therapeutics SAS

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Chronos Therapeutics Ltd.

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Curemark LLC

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

9.       Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.1.     Global Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Alcohol Addiction Therapeutics Market Forecast by Regions (2017-2027)

9.2.1.  North America Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.1.1.  United States Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.1.2.  Canada Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.1.3.  Mexico Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.  Europe Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.1.  Germany Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.2.  France Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.3.  UK Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.4.  Russia Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.5.  Italy Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.1.  China Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.2.  Japan Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.3.  Korea Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.4.  India Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.4.  South America Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.4.1.  Brazil Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.4.2.  Argentina Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.4.3.  Columbia Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.3.  Egypt Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.4.  Nigeria Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.5.  South Africa Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.6.  Turkey Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Alcohol Addiction Therapeutics Market Forecast (2017-2027)

9.3.     Alcohol Addiction Therapeutics Market Forecast by Product Type (2017-2027)

9.3.1.  Alcohol Addiction Therapeutics Forecast by Product Type (2017-2027)

9.3.2.  Alcohol Addiction Therapeutics Market Share Forecast by Product Type (2017-2027)

9.4.     Alcohol Addiction Therapeutics Market Forecast by Application (2017-2027)

9.4.1.  Alcohol Addiction Therapeutics Forecast by Application (2017-2027)

9.4.2.  Alcohol Addiction Therapeutics Market Share Forecast by Application (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Alcohol Addiction Therapeutics Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Alcohol Addiction Therapeutics Revenue and Revenue Share by Product Type (2017-2018)
Figure Global ADX-71441 Revenue and Growth Rate (2017-2018)
Figure Global ABT-436 Revenue and Growth Rate (2017-2018)
Figure Global A-705253 Revenue and Growth Rate (2017-2018)
Figure Global CTDP-002 Revenue and Growth Rate (2017-2018)
Figure Global CM-1212 Revenue and Growth Rate (2017-2018)
Table Global Alcohol Addiction Therapeutics Revenue and Revenue Share by Application (2017-2018)
Figure Global Clinic Revenue and Growth Rate (2017-2018)
Figure Global Hospital Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Alcohol Addiction Therapeutics Revenue by Regions (2017-2018)
Figure North America Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure North America Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2018)
Figure North America Alcohol Addiction Therapeutics by Countries (2017-2018)
Figure North America Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure United States Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure United States Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Canada Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Mexico Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Europe Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2018)
Figure Europe Alcohol Addiction Therapeutics by Countries (2017-2018)
Figure Europe Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Germany Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Germany Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure France Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure UK Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Russia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Italy Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Rest of Europe Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Asia-Pacific Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Alcohol Addiction Therapeutics by Countries (2017-2018)
Figure Asia-Pacific Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure China Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure China Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Japan Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Korea Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure India Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Southeast Asia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure South America Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2018)
Figure South America Alcohol Addiction Therapeutics by Countries (2017-2018)
Figure South America Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Brazil Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Argentina Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Columbia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Rest of South America Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Middle East and Africa Alcohol Addiction Therapeutics Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Alcohol Addiction Therapeutics by Countries (2017-2018)
Figure Middle East and Africa Alcohol Addiction Therapeutics Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Saudi Arabia Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure United Arab Emirates Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Egypt Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Nigeria Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure South Africa Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Turkey Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Alcohol Addiction Therapeutics Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2017-2018)
Table AstraZeneca Plc Alcohol Addiction Therapeutics Financial Overview
Table Allergan plc Alcohol Addiction Therapeutics Financial Overview
Table Purdue Pharma L.P Alcohol Addiction Therapeutics Financial Overview
Table GlaxoSmithKiline plc Alcohol Addiction Therapeutics Financial Overview
Table Cipla Ltd. Alcohol Addiction Therapeutics Financial Overview
Table Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Financial Overview
Table Pfizer Inc. Alcohol Addiction Therapeutics Financial Overview
Table Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Financial Overview
Table Chronos Therapeutics Ltd. Alcohol Addiction Therapeutics Financial Overview
Table Curemark LLC Alcohol Addiction Therapeutics Financial Overview
Figure Global Alcohol Addiction Therapeutics Revenue (Millions USD) and Growth Rate (2018-2025)
Table Alcohol Addiction Therapeutics Market Forecast by Regions (2018-2025)
Figure North America Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure United States Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Canada Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Mexico Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Europe Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Germany Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure France Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure UK Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Russia Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Italy Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Rest of Europe Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Asia-Pacific Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure China Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Japan Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Korea Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure India Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Southeast Asia Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure South America Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Brazil Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Argentina Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Columbia Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Rest of South America Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Middle East and Africa Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Saudi Arabia Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure United Arab Emirates Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Egypt Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Nigeria Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure South Africa Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Turkey Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Alcohol Addiction Therapeutics Market Forecast (2018-2025)
Figure Global Alcohol Addiction Therapeutics Forecast by Product Type (2018-2025)
Figure Global Alcohol Addiction Therapeutics Market Share Forecast by Product Type (2018-2025)
Figure Global Alcohol Addiction Therapeutics Forecast by Product Type (2018-2025)
Figure Global Alcohol Addiction Therapeutics Forecast by Application (2018-2025)
Figure Global Alcohol Addiction Therapeutics Market Share Forecast by Application (2018-2025)
Figure Global Alcohol Addiction Therapeutics Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*